Neurontin and Requip drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Neurontin (gabapentin) and Requip (ropinirole hydrochloride). Common drug interactions include anxiety among females and neuropathy peripheral among males.
The phase IV clinical study analyzes what interactions people have when they take Neurontin and Requip. It is created by eHealthMe based on reports of 1,301 people who take the same drugs from the FDA, and is updated regularly.
What is Neurontin?
Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 107,468 Neurontin users. Check the latest studies of Neurontin.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
1,301 people who take Neurontin and Requip together, and have interactions are studied.
What are the common drug interactions of Neurontin and Requip, by gender? *
What are the common drug interactions of Neurontin and Requip, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Neurontin and Requip?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Neurontin and Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Neurontin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Neurontin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and ropinirole hydrochloride (the active ingredients of Neurontin and Requip, respectively), and Neurontin and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lupron Depot-3 and Lipitor - now
- Could Escitalopram cause Cardiac Valve Disease? - 3 seconds ago
- Drug interactions of Mucinex and Orgovyx - 3 seconds ago
- Could Actos cause Impaired Work Ability? - 8 seconds ago
- Adderall vs. Hydrocortisone, side effect and effectiveness comparison - 8 seconds ago
- Drug interactions of Topiramate and Actos - 10 seconds ago
- Could Sunitinib Malate cause Azotaemia? - 13 seconds ago
- Could Ketek cause Hepatic Function Abnormal? - 18 seconds ago
- Could Qulipta cause Dyspnea Exacerbated? - 23 seconds ago
- Drug interactions of Mirena and Guaifenesin - 25 seconds ago